| scholarly article | Q13442814 |
| P356 | DOI | 10.4049/JIMMUNOL.1003761 |
| P698 | PubMed publication ID | 21411735 |
| P50 | author | Nobuhiko Kamada | Q43115881 |
| Gabriel Núñez | Q63409996 | ||
| P2093 | author name string | Naohiro Inohara | |
| Yun-Gi Kim | |||
| Mizuho Hasegawa | |||
| Kazuki Tawaratsumida | |||
| Takashi Yamazaki | |||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | neutrophil recruitment | Q106615276 |
| Clostridium difficile | Q310543 | ||
| P1104 | number of pages | 9 | |
| P304 | page(s) | 4872-4880 | |
| P577 | publication date | 2011-03-16 | |
| P1433 | published in | Journal of Immunology | Q3521441 |
| P1476 | title | Nucleotide-binding oligomerization domain 1 mediates recognition of Clostridium difficile and induces neutrophil recruitment and protection against the pathogen | |
| P478 | volume | 186 |
| Q61448770 | Activation of Both TLR and NOD Signaling Confers Host Innate Immunity-Mediated Protection Against Microbial Infection |
| Q50998497 | Acute infection of mice with Clostridium difficile leads to eIF2α phosphorylation and pro-survival signalling as part of the mucosal inflammatory response. |
| Q36188444 | Antibiotics, microbiota, and immune defense |
| Q59134753 | Apoptosis of intestinal epithelial cells restricts Clostridium difficile infection in a model of pseudomembranous colitis |
| Q26861114 | Calcineurin/NFAT signaling and innate host defence: a role for NOD1-mediated phagocytic functions |
| Q34078745 | Changes in cecal microbiota and mucosal gene expression revealed new aspects of epizootic rabbit enteropathy |
| Q36116428 | Clostridium difficile colitis: pathogenesis and host defence |
| Q60500782 | Clostridium difficile infection |
| Q34904239 | Clostridium difficile modulates host innate immunity via toxin-independent and dependent mechanism(s). |
| Q34405411 | Clostridium difficile spore-macrophage interactions: spore survival |
| Q35973168 | Colonization Resistance of the Gut Microbiota against Clostridium difficile |
| Q36253681 | Could a swimming creature inform us on intestinal diseases? Lessons from zebrafish |
| Q36163076 | Critical role for MyD88-mediated neutrophil recruitment during Clostridium difficile colitis. |
| Q34574874 | Cyclosporine A impairs nucleotide binding oligomerization domain (Nod1)-mediated innate antibacterial renal defenses in mice and human transplant recipients |
| Q38177269 | Debug Your Bugs - How NLRs Shape Intestinal Host-Microbe Interactions |
| Q26825638 | Disruptions of Host Immunity and Inflammation by Giardia Duodenalis: Potential Consequences for Co-Infections in the Gastro-Intestinal Tract |
| Q37997735 | Effector functions of NLRs in the intestine: innate sensing, cell death, and disease |
| Q37619440 | Emerging roles of immunostimulatory oral bacteria in periodontitis development |
| Q91890422 | Epithelium-specific MyD88 signaling, but not DCs or macrophages, control acute intestinal infection with Clostridium difficile |
| Q37943794 | Expression and functional importance of innate immune receptors by intestinal epithelial cells |
| Q57150262 | FECAL HOST TRANSCRIPTOMICS FOR NON-INVASIVE HUMAN MUCOSAL IMMUNE PROFILING: PROOF OF CONCEPT IN INFECTION |
| Q47641276 | Faecalibacterium prausnitzii and a Prebiotic Protect Intestinal Health in a Mouse Model of Antibiotic and Clostridium difficile Exposure |
| Q37515104 | Familial Mediterranean fever mutations lift the obligatory requirement for microtubules in Pyrin inflammasome activation |
| Q31147407 | Fecal microbiota transplantation: effectiveness, complexities, and lingering concerns |
| Q99561717 | Gut microbiota, NLR proteins, and intestinal homeostasis |
| Q34595635 | Host immunity to Clostridium difficile PCR ribotype 017 strains |
| Q27026464 | Host recognition of Clostridium difficile and the innate immune response |
| Q30416692 | Immune responses to Clostridium difficile infection |
| Q37040382 | Induction of bone loss by pathobiont-mediated Nod1 signaling in the oral cavity |
| Q30300885 | Inflammasome activation contributes to interleukin-23 production in response to Clostridium difficile |
| Q35957398 | Innate Immune Defenses Mediated by Two ILC Subsets Are Critical for Protection against Acute Clostridium difficile Infection |
| Q45068991 | Innate immune response and outcome of Clostridium difficile infection are dependent on fecal bacterial composition in the aged host |
| Q27002611 | Innate immune signaling in defense against intestinal microbes |
| Q38026748 | Innate immune signalling at the intestinal epithelium in homeostasis and disease. |
| Q57253397 | Innate immunity in the small intestine |
| Q41696303 | Interleukin-22 and CD160 play additive roles in the host mucosal response to Clostridium difficile infection in mice |
| Q34453038 | Interleukin-22 regulates the complement system to promote resistance against pathobionts after pathogen-induced intestinal damage. |
| Q40444654 | Interleukin-23 (IL-23), independent of IL-17 and IL-22, drives neutrophil recruitment and innate inflammation during Clostridium difficile colitis in mice |
| Q35714248 | Interrelatedness between dysbiosis in the gut microbiota due to immunodeficiency and disease penetrance of colitis |
| Q40150071 | Is Clostridium difficile infection a risk factor for subsequent bloodstream infection? |
| Q92921981 | Microbiota-Immune Interaction in the Pathogenesis of Gut-Derived Infection |
| Q34324937 | Microbiota-mediated colonization resistance against intestinal pathogens |
| Q38060719 | NOD1 and NOD2 Signaling in Infection and Inflammation. |
| Q47795296 | NOD1 and NOD2 receptors in mrigal (Cirrhinus mrigala): inductive expression and downstream signalling in ligand stimulation and bacterial infections |
| Q34745603 | NOD1 and NOD2: signaling, host defense, and inflammatory disease |
| Q33774237 | NOD1 deficiency impairs CD44a/Lck as well as PI3K/Akt pathway |
| Q38804174 | Neutrophil-mediated inflammation in the pathogenesis of Clostridium difficile infections |
| Q90204181 | New Host-Directed Therapeutics for the Treatment of Clostridioides difficile Infection |
| Q35098190 | New role for human α-defensin 5 in the fight against hypervirulent Clostridium difficile strains |
| Q41986771 | Nucleotide-binding oligomerization domain 1 and gastrointestinal disorders |
| Q34309329 | Nucleotide-oligomerizing domain-1 (NOD1) receptor activation induces pro-inflammatory responses and autophagy in human alveolar macrophages |
| Q30251941 | Older Is Not Wiser, Immunologically Speaking: Effect of Aging on Host Response to Clostridium difficile Infections |
| Q92717907 | Persistent Systemic Microbial Translocation, Inflammation, and Intestinal Damage During Clostridioides difficile Infection |
| Q51737047 | Preterm Life in Sterile Conditions: A Study on Preterm, Germ-Free Piglets. |
| Q41892852 | Protective role of commensals against Clostridium difficile infection via an IL-1β-mediated positive-feedback loop |
| Q34081385 | Regulation of the gut microbiota by the mucosal immune system in mice |
| Q42205221 | Role of GM-CSF in the inflammatory cytokine network that regulates neutrophil influx into the colonic mucosa during Clostridium difficile infection in mice |
| Q39084786 | Role of interferon-γ and inflammatory monocytes in driving colonic inflammation during acute Clostridium difficile infection in mice |
| Q30412148 | Role of leptin-mediated colonic inflammation in defense against Clostridium difficile colitis |
| Q35201232 | Role of microbiota and innate immunity in recurrent Clostridium difficile infection. |
| Q35448732 | Role of the commensal microbiota in normal and pathogenic host immune responses |
| Q35448563 | Salmonella enterica serovar Typhimurium ΔmsbB triggers exacerbated inflammation in Nod2 deficient mice. |
| Q54977805 | TPL2 is a key regulator of intestinal inflammation in C. difficile infection. |
| Q37643862 | TREM-1 promotes survival during Klebsiella pneumoniae liver abscess in mice |
| Q52332673 | The ATP-P2X7 Signaling Axis Is an Essential Sentinel for Intracellular Clostridium difficile Pathogen-Induced Inflammasome Activation. |
| Q55311368 | The NFκB signaling pathway serves an important regulatory role in Klebsiella pneumoniae liver abscesses. |
| Q42020494 | The P2Y6 receptor mediates Clostridium difficile toxin-induced CXCL8/IL-8 production and intestinal epithelial barrier dysfunction |
| Q27021111 | The Role of Oral Pathobionts in Dysbiosis during Periodontitis Development |
| Q38234947 | The dual role of nod-like receptors in mucosal innate immunity and chronic intestinal inflammation |
| Q35577842 | The interplay between microbiome dynamics and pathogen dynamics in a murine model of Clostridium difficile Infection |
| Q26862848 | The intestinal microbiota and susceptibility to infection in immunocompromised patients |
| Q30276756 | The microbiota and immune response during Clostridium difficile infection |
| Q35423526 | The role of Gr-1(+) cells and tumour necrosis factor-α signalling during Clostridium difficile colitis in mice |
| Q36995532 | The role of the innate immune system in destruction of pancreatic beta cells in NOD mice and humans with type I diabetes |
| Q47734724 | The role of toxins in Clostridium difficile infection. |
| Q34623572 | The roles of host and pathogen factors and the innate immune response in the pathogenesis of Clostridium difficile infection |
| Q28676201 | Therapeutic targeting of NOD1 receptors |
| Q91672773 | Translation of peptidoglycan metabolites into immunotherapeutics |
| Q33880455 | Tryptophan catabolism restricts IFN-γ-expressing neutrophils and Clostridium difficile immunopathology |
| Q90388993 | Type 3 Immunity during Clostridioides difficile Infection: Too Much of a Good Thing? |
| Q34555956 | Use of direct gradient analysis to uncover biological hypotheses in 16s survey data and beyond |
| Q40475060 | [Clostridium difficile infection : What is currently available for treatment?] |
Search more.